Cargando…

OA01. 35. Role of matravasti as rasayana in jarajanya vikara - A clinical study

PURPOSE: To prove whether Matravasti shows multiple effects on different systems in old people and to substantiate the effects of Matravasti and Rasayana on clinical basis in ageing. METHOD: Eighty two patients - Men of age group 50 - 80 years; Women aged above 45 years or who have attained Menopaus...

Descripción completa

Detalles Bibliográficos
Autores principales: Dornala, Sathyanarayana, Sharma, Om Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800913/
Descripción
Sumario:PURPOSE: To prove whether Matravasti shows multiple effects on different systems in old people and to substantiate the effects of Matravasti and Rasayana on clinical basis in ageing. METHOD: Eighty two patients - Men of age group 50 - 80 years; Women aged above 45 years or who have attained Menopause and <75 years suffering from common problems of old age irrespective of sex, caste, religion etc. were registered for the study from the OPD of MCD Ayurvedic Dispensary, Krishna Nagar, Delhi and OPD and IPD of PG Dept. of Panchakarma, Madhav vilas hospital, Jaipur. Out of which, 16 patients dropped out did not complete treatment. Matravasti was administered for 21 times with Balashwagandha lakshadi (BAL) Taila on alternate days with a dosage 30 - 80 ml accordingly. After completion of 21 days of Matravasti, all the patients were reviewed for successive 6 months. All the cases were assessed by considering 15 different aspects reflecting the common problems of ageing like Activities of Daily Living (ADL), Instrumental Activities of Daily Living (IADL) etc., RESULT: The overall effect and maximum benefit observed was FAIR (25 % - 50 %) in 38 cases out of 66 patients. GOOD response (51 - 75 % response) in 26 cases and remaining 2 cases Best response (>75%). And the maximum benefit observed among all the cases is 81.8 % and the least effect was 25 %. Among all clinical parameters considered for the study maximum efficacy was found in sleep disturbances (67.5%) followed with gait balance deficit (56.25%), emotional status (55.1%), urinary incontinence (55%), Mobility (53.96 %), IADL (51.3%), ADL(50.8%), constipation (49.5%), cognitive status (48.78%), pain (48.14%), dyspnoea (47.25%), hearing impairment (42.5%), visual impairment (41.8%), dermatological manifestations (41.17%), and involuntary movements (22.2%). CONCLUSION: Matravasti is a multifaceted and highly effective therapeutic measure in the geriatric conditions.